Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel antitumor agents for both leukemias and solid tumors discovered by Taiwanese scientists

Nov. 26, 1999

Xenova's IND for multidrug resistance modulator gets FDA approval

Nov. 26, 1999

AACR-NCI-EORTC news: Japanese research team presents new hypoxic cell radiosensitizing agent

Nov. 25, 1999

Mount Sinai investigators describe novel apoptosis-inducing agent at scientific forum

Nov. 25, 1999

BASF discloses protein kinase inhibitors useful as antiangiogenic agents

Nov. 25, 1999

Calcium entry blockers with potential in the treatment of prostate cancer

Nov. 25, 1999

Valentis initiates phase IIa trial of IFN-alpha gene medicine in angiosarcoma

Nov. 25, 1999

Combination therapy containing GTI-2040 shows remarkable antitumor activity

Nov. 25, 1999

More promising cancer news from AACR-NCI-EORTC: Hughes Institute presents new compounds

Nov. 24, 1999

Radicicol derivative KF-58333 is a promising antileukemia agent

Nov. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...